Gotthardt M - Search Results

1

18F-2-deoxy-2-fluoro-D-glucose positron emission tomography, computed tomography, and magnetic resonance imaging for the detection of experimental colorectal liver metastases.

de Jong GM, Hendriks T, Bleichrodt RP, Dekker HM, Mus RD, Gotthardt M, Visser EP, Oyen WJ, Boerman OC. de Jong GM, et al. Among authors: gotthardt m. Mol Imaging. 2012 Apr;11(2):148-54. Mol Imaging. 2012. PMID: 22469242

2

Improved tumour detection by gastrin receptor scintigraphy in patients with metastasised medullary thyroid carcinoma.

Gotthardt M, Béhé MP, Beuter D, Battmann A, Bauhofer A, Schurrat T, Schipper M, Pollum H, Oyen WJ, Behr TM. Gotthardt M, et al. Eur J Nucl Med Mol Imaging. 2006 Nov;33(11):1273-9. doi: 10.1007/s00259-006-0157-8. Epub 2006 Jul 11. Eur J Nucl Med Mol Imaging. 2006. PMID: 16832634

3

A new technique for in vivo imaging of specific GLP-1 binding sites: first results in small rodents.

Gotthardt M, Lalyko G, van Eerd-Vismale J, Keil B, Schurrat T, Hower M, Laverman P, Behr TM, Boerman OC, Göke B, Béhé M. Gotthardt M, et al. Regul Pept. 2006 Dec 10;137(3):162-7. doi: 10.1016/j.regpep.2006.07.005. Epub 2006 Aug 22. Regul Pept. 2006. PMID: 16930741

4

What is the best pre-therapeutic dosimetry for successful radioiodine therapy of multifocal autonomy?

Gotthardt M, Rubner C, Bauhofer A, Berce F, Oyen WJ, Goecke J, Pfestroff A, Schlieck A, Corstens FH, Béhé M, Behr TM. Gotthardt M, et al. Nuklearmedizin. 2006;45(5):206-12. Nuklearmedizin. 2006. PMID: 17043731

5

Nuclear medicine imaging and therapy of neuroendocrine tumours.

Gotthardt M, Dijkgraaf I, Boerman OC, Oyen WJ. Gotthardt M, et al. Cancer Imaging. 2006 Oct 31;6(Spec No A):S178-84. doi: 10.1102/1470-7330.2006.9038. Cancer Imaging. 2006. PMID: 17114073 Free PMC article.

6

Added value of gastrin receptor scintigraphy in comparison to somatostatin receptor scintigraphy in patients with carcinoids and other neuroendocrine tumours.

Gotthardt M, Béhé MP, Grass J, Bauhofer A, Rinke A, Schipper ML, Kalinowski M, Arnold R, Oyen WJ, Behr TM. Gotthardt M, et al. Endocr Relat Cancer. 2006 Dec;13(4):1203-11. doi: 10.1677/erc.1.01245. Endocr Relat Cancer. 2006. PMID: 17158765

7

Indication for different mechanisms of kidney uptake of radiolabeled peptides.

Gotthardt M, van Eerd-Vismale J, Oyen WJ, de Jong M, Zhang H, Rolleman E, Maecke HR, Béhé M, Boerman O. Gotthardt M, et al. J Nucl Med. 2007 Apr;48(4):596-601. doi: 10.2967/jnumed.106.036020. J Nucl Med. 2007. PMID: 17401097 Free article.

8

Development and application of peptide-based radiopharmaceuticals.

Dijkgraaf I, Boerman OC, Oyen WJ, Corstens FH, Gotthardt M. Dijkgraaf I, et al. Among authors: gotthardt m. Anticancer Agents Med Chem. 2007 Sep;7(5):543-51. doi: 10.2174/187152007781668733. Anticancer Agents Med Chem. 2007. PMID: 17896914 Review.

9

Targeting of a CCK(2) receptor splice variant with (111)In-labelled cholecystokinin-8 (CCK8) and (111)In-labelled minigastrin.

Laverman P, Roosenburg S, Gotthardt M, Park J, Oyen WJ, de Jong M, Hellmich MR, Rutjes FP, van Delft FL, Boerman OC. Laverman P, et al. Among authors: gotthardt m. Eur J Nucl Med Mol Imaging. 2008 Feb;35(2):386-92. doi: 10.1007/s00259-007-0604-1. Epub 2007 Oct 13. Eur J Nucl Med Mol Imaging. 2008. PMID: 17934729

10

Molecular imaging of reduced renal uptake of radiolabelled [DOTA0,Tyr3]octreotate by the combination of lysine and Gelofusine in rats.

Rolleman EJ, Bernard BF, Breeman WA, Forrer F, de Blois E, Hoppin J, Gotthardt M, Boerman OC, Krenning EP, de Jong M. Rolleman EJ, et al. Among authors: gotthardt m. Nuklearmedizin. 2008;47(3):110-5. doi: 10.3413/nukmed-0069. Nuklearmedizin. 2008. PMID: 18493690

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

314 results

Search Page

Filters